REGN

Regeneron

$725.34

+21.03 (+2.99%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 20.11.2025
$749.21
(+3.29%)
Strong Buy: 4
Buy: 15
Hold: 6
Sell: 0
Strong Sell: 1
Description:
Regeneron Pharmaceuticals, Inc. is a leading American biotechnology company based in Westchester County, New York, recognized for its innovative research in monoclonal antibodies and therapeutic proteins. The company has established a strong presence in key therapeutic areas, including oncology, ophthalmology, and immunology, with flagship products such as Eylea and Dupixent driving its success. Regeneron maintains a robust product pipeline, underscoring its dedication to scientific advancement and its influential role in addressing critical unmet medical needs within the biopharmaceutical industry.
Exchange:
NASDAQ
Country:
USA
Sector:
HEALTHCARE
Industry:
BIOTECHNOLOGY
Address:
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, UNITED STATES, 10591-6707
Fiscal year end:
December
Market capitalization:
$76.9 Billion
EBITDA:
$4.35 Billion
PERatio:
17.39
EPS:
41.71
Dividend per share:
$2.64
Dividend yield:
0.37%
Beta:
0.386

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
+17%
How much will you get:
$1,174
Prices dates:
30-10-2015: $555.04 and 31-10-2025: $651.80